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-ABSTRACT 
The purpose of this study was to investigate the role ofleptin, an anti-obesity 
hormone, in immune responsiveness (i.e. proliferation) of murine T lymphocytes, in 
vitro, to the mitogenic stimulation of concanavalin A and anti-CD3 antibodies. 
Splenocytes were obtained from 3 to 6 month old male and female BALB/C mice and 
were cultured in the presence of media alone, Con A or anti-CD3, both with and without 
leptin. MTT uptake analysis was used to measure the amount of proliferation. 
Several proliferation studies were conducted, both with concanavalin A and with 
anti-CD3 antibodies. The optimum concentrations of Con A and leptin had been 
established by previous work in our laboratory, and we established the optimum 
concentration of anti-CD3 for maximum cellular proliferation. Our findings indicate that 
-
leptin alone is slightly stimulatory only in concentrations up to 20 ng/ml. Leptin, upon 
costimulation with either Con A or anti-CD3 antibodies, was stimulatory only at a 
concentration of 2 ng/ml. Above this concentration, leptin seems to be an 
immunosuppressor, at both high and low cell concentrations. 
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IntroductionlReview of Literature 
Leptin, a 16-kDa nonglycosylated peptide hormone, is synthesized only in 
adipocyte cells (10). It has a 4 alpha helical structure, similar to that of cytokines. Leptin 
is a product of the obese gene, ob. The ob gene has been localized to chromosome 
7q31.3 in humans, and chromosome 6 in mice. In both humans and mice, the gene 
consists of three exons. The mouse ob gene product encodes a 4.5 kb mRNA, while the 
human gene encodes a 3.5 kb mRNA. Despite these differences, the amino acid 
sequence of the two proteins exhibit 84% homology (6). 
The leptin receptor, OB-R, is encoded by the db gene. It belongs to the class I 
cytokine receptor family (10). Multiple forms of the receptor have been identified, 
varying in length of their intracytoplasmic tail. The long form (ObRb) is the most 
abundant and is the most competent in intra-cellular signaling in leptin-treated cells (6). 
Once leptin binds to its receptor, it decreases food intake and increases energy 
dissipation. This is its predominant function. Leptin serves as a peripheral signal to the 
brain (1) by binding to its receptor located in the hypothalamus (7). Serum levels of 
leptin correlate to total body fat. A study by Considine, et aI., found that the mean serum 
levels ofleptin were 31.3 ± 24.1 ng/ml in the obese subjects (body-mass index of~ 27.8) 
and 7.5 ± 9.3 ng/ml in the normal-weight patients. Weight loss in the obese subjects 
caused a reduction in leptin serum levels (2). Mutant obese mice (ob/ob), lack active 
leptin. When given injections of recombinant leptin, these mutant mice can be returned 
to normal weight (1). These findings led to much speculation that the same sort of 
therapy could work with obese humans. Obese humans, however, have elevated levels of 
leptin. Many studies have shown that obese humans tend to just be "leptin resistant", in 
-
that they do not generate a signal that corresponds to their elevated serum leptin levels, 
possibly due to a defective transport ofleptin across the blood-brain barrier or a defective 
ObR (1). A study by Esler, et aI., found that "the release ofleptin from the brain to the 
circulation was higher in obese than lean men, suggesting that the rise in plasma leptin 
concentration in human obesity is not entirely attributable to increased release of leptin 
from adipose tissue." These results suggested that leptin release could come from tissues 
other than adipose tissue, and the primary flaw causing obesity may be an inability of 
leptin to react with the central nervous system (5). 
The leptin receptor is not only expressed in the central nervous system. It is also 
found on other cells in reproductive and hematopoietic tissues (10). This has led to 
research into possible roles ofleptin in other systems. Indeed, leptin has been linked with 
fertility. Mutant oblob mice never progress to puberty. When leptin was administered to 
female oblob mice for 30 days, pregnancy was possible (6). Leptin has also been shown 
to accelerate puberty in normal mice. Leptin may be a signal to the body that it has 
stored up sufficient adipose tissue for reproduction, so that it may enter puberty (6). 
Because leptin receptors are found on hematopoietic tissues, it is thought that it 
probably also plays a regulatory role in hematopoiesis. The structures of both leptin and 
its receptor are very similar to many of the molecules that are involved in the regulation 
of hematopoiesis. In possible support of this hypothesis, mice that are deficient in either 
leptin or its receptor exhibit minor hemopoietic deficiencies (6). 
Leptin is a multi-functional protein that seems to affect a variety of systems in the 
body. One other system that has become a focus of leptin research is the immune system. 
Leptin has recently been shown to enhance cell-mediated immunity in mice. It can 
-
reverse starvation-induced immunosuppression in mice (9). In Martin-Romero's study, 
human recombinant leptin (16 - 1,600 nglml) was found to enhance the activation effect 
of submaximal concentrations of mitogens such as PHA or Con A on human peripheral 
lymphocytes depleted of monocytes. This indicates that leptin alone may not be 
sufficient to trigger the activation and proliferation ofT lymphocytes, but that it may be 
able to enhance the effect of other more powerful stimuli (10). It also appears that the 
effect of leptin is much more pronounced on CD4+ CD45RA +, or naIve, T cells than on 
memory T cells. Both of these cells express ObRb mRNA (9). The possible mechanism 
for this immunostimulatory action is not yet known. One possibility is that falling leptin 
serum levels act as a signal to the brain that the body is going into starvation. This causes 
the body to conserve energy. Energy is preserved for vital functions, such as energy 
metabolism, and less essential systems with high energy demands, such as the 
reproductive and immune systems, are inhibited (9). Lord found that stimulation of T 
lymphocytes by leptin was due to a specific effect of leptin receptor signaling. ObRb 
mRNA was detected in human CD4+ T cells, but not in freshly isolated monocytes. 
These results indicated that leptin enhances the T-cell immune response by binding to its 
receptor on the T cells, rather than through a direct effect on the antigen presenting 
stimulatory cell (9). 
Surprisingly, in previous work in our laboratory, recombinant murine leptin was 
found to be inhibitory toward both Con A or LPS stimulated murine splenocytes in vitro 
(8). In the present study, we attempted to repeat and confirm these findings with 
maximal levels of Con A or anti-CD3 antibodies which stimulate T cells specifically. In 
this work, we determined whether or not murine leptin stimulated the proliferation of 
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murine splenocytes in vitro in the presence of media alone, Concanavalin A, or murine 
anti-CD3 antibodies. Overall, in an in vitro animal model, leptin appears to be a 
suppressor of T lymphocyte proliferation. At concentrations of leptin up to 20 ng/ml, it 
was slightly stimulatory on its own. When used together with either Con A or anti-CD3, 
leptin was only stimulatory at a concentration of 2 ng/ml. 
Materials and Methods 
Experimental Animals 
Three to six month old male and female BALB/C mice were obtained from the 
breeding colony maintained at Ball State University. The mice were housed and fed 
under conditions that meet the approval of the Ball State University Animal Care 
Committee. 
Solutions and Reagents 
The murine splenocytes were cultured in RPMI 1640 complete media (with 
Hepes) with penicillin, streptomycin, and antimycotic, 0.05 mMf3-Mercaptoethanol, and 
10% fetal calf serum. Recombinant murine leptin, produced in E. Coli, was purchased 
from Sigma Chemical, and dissolved in 100 ul sterile dd water and 900 ul ofHBSS with 
0.05% Triton-X to give a 0.1 mg/ml stock. Con A, produced by Canavalia ensiformis 
type IV, was purchased from Sigma Chemical. A 1 mg/ml stock was made in sterile 
media. Murine anti-CD3 antibody (0.5 mg/ml) was purchased from PharMingen 
International. A 40 ug/ml stock solution was made in sterile media . 
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Protocol for Proliferation Studies 
The mice were sacrificed by CO2 asphyxiation, and the spleen was removed. The 
cells were washed in HBSS and then adjusted to concentrations of 2.5 x 106 or 5 x 106 
cells/ml. The cells were added to a 96-well microtiter plate and Con A (4 ug/ml) or anti-
CD3 (0.2 ug/ml) was added to the cells. Wells containing cells and media alone were 
used as controls. Leptin was added to the cells in varying concentrations (Exp. 1 (Trials 
1 and 2): 2 ng/ml, 20 ng/ml, and 40 ng/ml; Exp. 1 (Trial 3) & Exp. 3: 2 ng/ml, 10 ng/ml, 
20 ng/ml, and 40 ng/ml). The cells were incubated in a CO2 incubator at 37° C for 
approximately 48 hours. After 48 hours, they were pulsed with MTT dye (5 mg/ml) and 
placed back into the incubator for 4-6 hours. The plate was then removed from the 
incubator and centrifuged. The supernatant was decanted and the stained cells were 
resuspended in 100 ul of 0.4% HCI acidified isopropanol. The optical densities of each 
well were read at 600 run using a Cambridge Technologies Series 700 Microplate Reader. 
Results 
Determination of optimum Concanavalin A concentrations: The optimal concentration 
for Con A was determined to be 4 ug/ml by previous work done in our lab. Thus, 4 
ug/ml Con A was used in all work except where noted. 
Experiment 1: Influence of leptin on Concanavalin A mitogenesis of spleen cells. Con 
A is often used to stimulate proliferation ofT lymphocytes. We examined the effect that 
leptin would have on this stimulation. As can be seen in Figures 1-6, when the 
splenocytes were stimulated with Con A, leptin showed a dose-dependent inhibition of 
proliferation. Table 1 has a summary of the percent inhibition or stimulation of 
proliferation by leptin, both with and without Con A. Without Con A stimulation, leptin 
at low concentrations seems to be slightly stimulatory, particularly at the higher cell 
concentrations. At higher levels, however, leptin suppressed proliferation of both 
stimulated and non-stimulated cells. A trial was also done in which two different 
concentrations of Con A were used (2 uglml and 4 uglml) in order to determine if one 
would be more effective (see Figure 7). No significant difference was seen between the 
immunosuppressive effect of leptin at 2 or 4 ug/ml Con A. 
Experiment 1: Determination of optimum anti-CD3 antibody concentrations. In order 
to determine the maximal concentration of murine anti-CD3 for T cell proliferation, cells 
were incubated in either media alone or various concentrations of anti-CD3 antibody (.01 
uglml, .1 uglml, and 1 uglml). The results are shown in Figure 8. The concentration that 
yielded maximum proliferation for both high and low cell concentrations was 0.1 ug/ml. 
In order to ensure that we would have significant cell proliferation, a concentration 
slightly above this maximal concentration was chosen (0.2 uglml). 
Experiment 3: Influence of leptin on anti-CD3 mitogenesis of spleen cells. In this 
experiment, we examined the effect of leptin on a second T cell mitogen, murine anti-
CD3 antibody. Only the higher cell concentration, 5 x 106 cells/ml, was used for this 
experiment. The results are shown in Figures 9 and 10 and the percents inhibition or 
stimulation are summarized in Table 2. Again, leptin suppressed cellular proliferation. 
Slight stimulation was seen at 2 ng/ml of leptin, but it was not significant. Without 
stimulation by anti-CD3, leptin showed stimulation at a concentration of 2 ng/ml, but 
suppression at all higher concentrations. 
Discussion 
Our research has shown that leptin is immunosuppressive at physiologically 
relevant levels when either Con A or anti-CD3 are used to stimulate lymphocytes. 
Murine recombinant leptin dose-dependently suppressed proliferation of murine T 
lymphocytes, especially at concentrations of 20 ng/ml and higher. This confirmed the 
previous research that had been done in our lab. The immunosuppression observed when 
anti-CD3 was used as the immune stimulant is particularly important as anti-CD3 most 
closely mimics MHC-Ag stimulation of T lymphocytes. Thus, it appears that excessive 
amounts of leptin observed in many obese individuals ~ of 31.3 ng/ml) may indeed be 
immunosuppressive, and that giving added leptin to obese individuals to induce weight 
loss, as has been suggested, could be detrimental. Leptin at low levels may be slightly 
stimulatory but at levels generally observed in normal weight individuals (~ 10 ng/mI), 
no stimulation was observed and at 20 ng/ml suppression was observed. 
Martin-Romero, et al. have reported that human leptin enhances activation and 
proliferation of human circulating T lymphocytes. They did not report any 
immunosuppressive effect of leptin. There are, however, some key differences between 
our research and the research done by Martin-Romero that could explain the differences 
in our findings. In their research, they used human lymphocytes and human recombinant 
leptin, while we used murine sources for both. Also, they used submaximal 
concentrations of Con A to stimulate their lymphocytes. These were the concentrations 
-that were used when leptin stimulated proliferation. The concentrations of Con A and 
anti-CD3 that we used were optimal concentrations. It is possible that, when optimal 
concentrations of mitogens are used, leptin causes suppression of proliferation, rather 
than stimulation. In addition, the concentrations of leptin that they used, 16-1,600 ng/ml, 
is much higher than the concentration used in our research, and is significantly higher 
than serum levels of leptin found in human or mice. It may be that leptin at 
physiologically relevant levels serves much more importantly as an immunomodulator 
enhancing certain functions and activities of subsets of lymphocytes, monocytes and 
macrophages rather than their proliferation. 
There is still much research that needs to be done on leptin and its role in rhe 
immune response. It seems to have a multitude of functions, and it is possible that not all 
of them have been discovered. It would be interesting to conduct these same experiments 
in vivo and see if the same results were obtained. 
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Stimulation with Con A (4 ug/ml) 
2.5 x 106 cells/ml 5 x 106 cells/ml 
Leptin (ng/ml) Without Con A With Con A Without Con A With Con A 
2 21.94% -5.50% 56.73% -2.55% 
(4.52 to 47.6%) (3.23 to -11.2%) (41.6 to 71.0%) (-1.99 to -2.88%) 
10 61.9% 3.02% -16.9% 6.17% 
20 -6.18% -32.0% 51.55% -27.90% 
(9.03 to -28.1 %) (-26.5 to -36.3%) (9.74 to 93.3%) (-7.9 to -57.0%) 
40 -8.86% -75.23% -30.97% -68.83% 
(10.6 to -40.4 %) (-68.7 to -79.7 %) (-13.9 to -47.7%) (-65.2 to -75.9%) 
. ... Table 1: Percent stimulation (+) or mhlbltlOn (-) With leptin. Percentages shown are mean values of three trIals, 
except for the 10 nglmlleptin concentration (with the range in parentheses). 
Stimulation with murine anti-CD3 antibody (0.2 ug/ml) 
Leptin (ng/ml) Without anti-CD3 With anti-CD3 
2 100.1% 1.3% 
(28.2 to 172%) (7.1 to -4.5%) 
10 -2.1% -13.5% 
(12.8 to -16.9%) (-4.0 to -22.9%) 
20 -18.7% -36.4% 
(-18.2 to -19.1%) (-33.5 to -39.3%) 
40 -42.9% -68.7% 
(-21.3 to -64.5%) (-63.4 to -73.9%) 
. . ... Table 2: Percent stimulation (+) or mhlbltion (-) with leptm. Percentages shown are mean values of two tnals 
(with the range in parentheses). Cell concentrations for all trials of this experiment were 5 x 106 cells/ml. 
Experiment 1: Effect of leptin - with and without Con A (Trial 1) 
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Figure 1: 0.0. readings shown are mean values + 1 S.D. 
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_ Figure 2: O.D. readings shown are mean values + 1 S.D. 
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Experiment 1: Effect of leptin - with and without Con A (Trial 2) 
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Figure 3: 0.0. readings shown are mean values + 1 S.D. 
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Figure 4: 0.0. readings shown are mean values + 1 S.D. 
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Figure 5: 0.0. readings shown are mean values + 1 S.D. 
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Figure 6: 0.0. readings shown are mean values + 1 S.D. 
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Figure 7: Costimulation with 2 ug/ml and 4 ug/ml Con A (0.0. readings shown are 
mean values + 1 S.D. 
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Figure 8: Determination of maximal concentration of anti-CD3 
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